Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Popular

    Popular

    FDA expands approval of Gilenya to treat multiple sclerosis in pediatric patients

    FDA expands approval of Gilenya to treat multiple sclerosis in pediatric patients

    Medical Dialogues Bureau12 May 2018 6:30 AM GMT
    The U.S. Food and Drug Administration today approved Gilenya (fingolimod) to treat relapsing multiple sclerosis (MS) in children and adolescents age...
    Hazards of Anaesthesia medicines with look-alike packaging: Study

    Hazards of Anaesthesia medicines with look-alike packaging: Study

    Ruby Khatun Khatun27 Nov 2017 6:09 AM GMT
    Mumbai: Anesthesiologist from KEM hospital have shown and raised their concerns about the hazards of the look-alike packaging of intravenous drugs.A...
    FDA shuts six medical stores in Haryana due to irregularities

    FDA shuts six medical stores in Haryana due to irregularities

    Ruby Khatun Khatun14 July 2017 4:21 AM GMT
    Chandigarh: Under its special search operation, the Haryana Food and Drugs Administration (FDA) sealed six shops in different areas of the state for...
    FDA approves first cancer treatment for any solid tumor with a specific genetic feature

    FDA approves first cancer treatment for any solid tumor with a specific genetic feature

    Ruby Khatun Khatun26 May 2017 4:08 AM GMT
    The U.S. Food and Drug Administration (FDA) granted accelerated approval to a treatment for patients whose cancers have a specific genetic feature...
    Government to frame new rules on medical devices to draw investments

    Government to frame new rules on medical devices to draw investments

    supriya kashyap kashyap2 Feb 2017 5:58 AM GMT
    New Delhi : Government said it will amend the Drugs and Cosmetics Rules to ensure availability of medicines at reasonable prices and also formulate...
    UK can help India bring best healthcare to smart cities: NHS chief

    UK can help India bring best healthcare to smart cities: NHS chief

    savita thakur thakur7 Jun 2016 9:48 AM GMT
    New Delhi : The United Kingdom can play a "significant" role in helping India bring the best healthcare solutions to its proposed smart cities, a top...
    Ratan Tata invests in MUrgency

    Ratan Tata invests in MUrgency

    savita thakur thakur18 May 2016 7:08 AM GMT
    New Delhi : Tata Sons Chairman Emeritus Ratan Tata has invested in San Francisco-based medical emergency response startup MUrgency Inc.Financial...
    Starpharma, Ansell to sell Anti-Zika Condoms For Olympics

    Starpharma, Ansell to sell Anti-Zika Condoms For Olympics

    savita thakur thakur17 May 2016 8:55 AM GMT
    Australian pharmaceutical company Starpharma Holdings Ltd said it is teaming up with world No. 2 condom maker Ansell Ltd to supply Zika virus-proof...
    NPPA Slashes price of another 54 Critical medcines. Check out the details

    NPPA Slashes price of another 54 Critical medcines. Check out the details

    Geeta Sharma Sharma14 May 2016 10:35 AM GMT
    The common man ailing from critical diseases has received a reliever through the recent National Pharmaceutical Pricing Authority (NPPA) directive to...

    Popular Stories

    FDA seizes unlicensed medical devices worth over Rs 1 crore from GT Hospital

    FDA seizes unlicensed medical devices worth over Rs 1 crore from GT Hospital

    Covid-19 Impact: NPPA asks drugmakers to submit availablility data of 58 APIs, details

    Covid-19 Impact: NPPA asks drugmakers to submit availablility data of 58 APIs, details

    Johnson & Johnson Risperdal Lawsuit: US Court Slashes USD 8 Billion Verdict

    Johnson & Johnson Risperdal Lawsuit: US Court Slashes USD 8 Billion Verdict

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Pharmaceuticals safe in PET packaging: High-level committee

    Pharmaceuticals safe in PET packaging: High-level committee

    Regulation of OTC drugs : CDSCO to soon amend Schedule K of Drugs and Cosmetics Act

    Regulation of OTC drugs : CDSCO to soon amend Schedule K of Drugs and Cosmetics Act

    Violation of price capping of Coronary stent to attract NPPA action; Minister

    Violation of price capping of Coronary stent to attract NPPA action; Minister

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier

    This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:

    Search only trustworthy HONcode health websites:

    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

    © 2020 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok